Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170,403,883
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
85,851,784
-
Shares change
-
+14,316,996
-
Total reported value, excl. options
-
$2,426,035,273
-
Value change
-
+$414,565,041
-
Put/Call ratio
-
21%
-
Number of buys
-
75
-
Number of sells
-
-42
-
Price
-
$28.31
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2020
147 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q3 2020.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85,851,784 shares
of 170,403,883 outstanding shares and own 50% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (21,571,764 shares), ARK Investment Management LLC (12,293,033 shares), FMR LLC (10,717,400 shares), BlackRock Inc. (6,021,285 shares), Nikko Asset Management Americas, Inc. (5,531,670 shares), Sumitomo Mitsui Trust Holdings, Inc. (5,531,670 shares), RA CAPITAL MANAGEMENT, L.P. (4,750,000 shares), GILDER GAGNON HOWE & CO LLC (3,185,420 shares), FEDERATED HERMES, INC. (2,789,667 shares), and VANGUARD GROUP INC (2,755,345 shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.